PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Ahlquist DA et al. Factors influencing metabolism of arachidonic acid in guinea pig gastric mucosa. 1983 Am. J. Physiol. pmid:6401937
Homma T and Malik KU Effect of secretin and caerulein in canine pancreas: relation to prostaglandins. 1983 Am. J. Physiol. pmid:6344655
Feinstein MB et al. Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin. 1983 J. Biol. Chem. pmid:6571835
Sakai T et al. Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells. 1983 Cancer Lett. pmid:6572553
Kootte AM et al. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. 1983 Neth J Med pmid:6572798
Abelson MB et al. Aspirin therapy in vernal conjunctivitis. 1983 Am. J. Ophthalmol. pmid:6573138
Gerritsen ME PGD2 formation in the vasculature: characteristics of rat tail vein prostaglandin endoperoxide-D isomerase. 1983 Prostaglandins pmid:6573722
Gaetani P et al. [Prostaglandin D2 in subarachnoid hemorrhage. Biological and diagnostic implications]. 1983 Jul-Aug Riv Patol Nerv Ment pmid:6598516
Brus R et al. Effect of prostaglandins on morphine-induced catalepsy in mice. 1983 Sep-Dec Acta Physiol Pol pmid:6679984
Bito LZ Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. 1984 Exp. Eye Res. pmid:6370708
Barrow SE et al. Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion. 1984 Prostaglandins pmid:6441188
Bertelé V et al. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products. 1984 Blood pmid:6426554
Peters SP et al. Arachidonic acid metabolism in purified human lung mast cells. 1984 J. Immunol. pmid:6199420
Gresele P et al. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. 1984 Biochem. Pharmacol. pmid:6430299
Vicenzi E et al. Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. 1984 Clin. Exp. Immunol. pmid:6432383
Nishi S et al. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release. 1984 Horm. Metab. Res. pmid:6152434
Tynan SS et al. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. 1984 Prostaglandins pmid:6087417
Neely SM et al. Mechanism and characteristics of platelet activation by haematin. 1984 Br. J. Haematol. pmid:6383458
Uchizono K [Studies of sleep inducing substance]. 1984 Nippon Rinsho pmid:6384575
Philips JB and Lyrene RK Prostaglandins, related compounds, and the perinatal pulmonary circulation. 1984 Clin Perinatol pmid:6386270
Goetzl EJ Asthma: new mediators and old problems. 1984 N. Engl. J. Med. pmid:6330554
Rao PS et al. Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. 1984 Am. J. Obstet. Gynecol. pmid:6424477
Schick B et al. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1984 J. Immunol. pmid:6425408
Dembinska-Kieć A et al. Formation of leukotriene C4-like material by rat brain tissue. 1984 Eur. J. Pharmacol. pmid:6426980
Kawamura M and Koshihara Y Prostaglandin D2 lowers nuclear DNA polymerase activity in cultured mastocytoma cells. 1984 Prostaglandins pmid:6427850
Vincent JE et al. The effect of 5-(2-chlorobenzyl)-5,6,7,7a-tetrahydro 4H-thieno (3.2-C)-pyridine-2-one hydrochloride (PCR 3787), a metabolite of ticlopidine, on the aggregation of human platelets in vitro and on the aggregation inhibiting action of PGI2 and PGD2. 1984 Prostaglandins Leukot Med pmid:6396655
Weichman BM et al. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro. 1984 J. Pharmacol. Exp. Ther. pmid:6582266
Higashida H et al. Facilitation of synaptic transmission by prostaglandin D2 at synapses between NG108-15 hybrid and muscle cells. 1984 Brain Res. pmid:6324947
Bertelé V et al. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. 1984 Thromb. Haemost. pmid:6326343
Chapnick BM Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow. 1984 Am. J. Physiol. pmid:6326595
Gardiner PJ and Browne JL Tussive activity of inhaled PGD2 in the cat and characterisation of the receptor(s) involved. 1984 Prostaglandins Leukot Med pmid:6328541
Zavoico GB and Feinstein MB Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. 1984 Biochem. Biophys. Res. Commun. pmid:6329175
Imanishi J et al. [Inhibition of the multiplication of human herpes virus I by prostaglandin D2 and the synergistic effect of human leukocyte interferon]. 1984 C. R. Seances Soc. Biol. Fil. pmid:6100083
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Nilsson J and Olsson AG Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. 1984 Atherosclerosis pmid:6093830
Mitsuma T and Nogimori T Effects of substance P, angiotensin II, oxotremorine and prostaglandin D2 on thyrotropin secretion in rats. 1984 Horm. Res. pmid:6201427
Ennis M et al. Prostaglandin and histamine release from stimulated rat peritoneal mast cells. 1984 Agents Actions pmid:6203356
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Ikai K et al. Prostaglandin D2 and prostaglandin D synthetase in mast cell deficient mice. 1984 Prostaglandins pmid:6435183
Holgate ST and Robinson C 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. 1984 Br. J. Pharmacol. pmid:6439267
Erman A and Nasjletti A Enhancement of renal medulla prostaglandin synthetase activity by dexamethasone treatment in the rat. 1984 Biochem. Biophys. Res. Commun. pmid:6428405
Holgate ST et al. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. 1984 J. Immunol. pmid:6206153
Schleimer RP et al. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. 1984 J. Allergy Clin. Immunol. pmid:6208229
Inoué S et al. Differential sleep-promoting effects of five sleep substances nocturnally infused in unrestrained rats. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6592612
Inoué S et al. Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. 1984 Neurosci. Lett. pmid:6593603
Peters SP et al. Effect of prostaglandin D2 in modulating histamine release from human basophils. 1984 J. Pharmacol. Exp. Ther. pmid:6198512
Marsden KA et al. The effect of prostaglandin D2 (PGD2) on circulating eosinophils. 1984 Prostaglandins Leukot Med pmid:6593748
Uemura S et al. Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. 1984 Pediatr. Res. pmid:6596550
Heavey DJ et al. Effects of intravenous infusions of prostaglandin D2 in man. 1984 Prostaglandins pmid:6596653
Mahmud I et al. On the identification and biological properties of prostaglandin J2. 1984 Prostaglandins Leukot Med pmid:6597446
Arisawa M et al. Direct suppressive effect of prostaglandin D2 on growth hormone secretion from rat anterior pituitary. 1984 Asia Oceania J Obstet Gynaecol pmid:6598030
Newman JH and Sheller JR Arachidonic acid metabolites in the healthy and diseased lung. 1984 Am. J. Med. Sci. pmid:6091454
Ogorochi T et al. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. 1984 J. Neurochem. pmid:6427411
Abramovich DR et al. The effect of prostaglandin D2 on the blood vessels of the perfused isolated cotyledon of the human placenta. 1984 Br. J. Pharmacol. pmid:6584189
Kikawa Y et al. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6584883
Sakai T et al. Prostaglandin D2 inhibits the proliferation of human malignant tumor cells. 1984 Prostaglandins pmid:6584941
Imashuku S et al. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma]. 1984 Gan To Kagaku Ryoho pmid:6585182
Nakajima M and Toda N Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries. 1984 Prostaglandins pmid:6587438
Andersen NH and Hartzell CJ High-field 1H NMR studies of prostaglandin H2 and its decomposition pathways. 1984 Biochem. Biophys. Res. Commun. pmid:6587849
Gal D et al. Effect of radiation on prostaglandin production by human bowel in vitro. 1984 Int. J. Radiat. Oncol. Biol. Phys. pmid:6588048
Shimatsu A et al. Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood. 1984 Mar-Apr Peptides pmid:6591147
Imashuku S et al. Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma. 1985 Prog. Clin. Biol. Res. pmid:2986176
Makino S [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. 1985 Nippon Rinsho pmid:2989584
Siegl AM and Daly JW Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets. 1985 J Cyclic Nucleotide Protein Phosphor Res pmid:2991349
Hall TJ et al. Decreased natural killer cell activity in atopic eczema. 1985 Immunology pmid:3876984
Förstermann U et al. Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2. 1985 Prostaglandins Leukot Med pmid:2991946
Hamid S and Whittle BJ Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. 1985 Br. J. Pharmacol. pmid:2992652
Narumiya S and Toda N Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. 1985 Br. J. Pharmacol. pmid:2992661
Bertelé V et al. Refractoriness of platelets to prostaglandins after infusion in rabbits. 1985 J. Lab. Clin. Med. pmid:2997353
Kimura H et al. Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro. 1985 Brain Res. pmid:2859088
Schick B and Austen KF Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1985 Immunology pmid:3935569
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Cutler LS et al. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2. 1985 Biochim. Biophys. Acta pmid:3890960
Siegl PK and Wenger HC Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog. 1985 Eur. J. Pharmacol. pmid:3899681
Regulatory control and standardization of allergenic extracts. Clinical studies with "standardized" extracts. 1985 Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M pmid:3901924
Kiyomiya K and Oh-ishi S Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. 1985 Jpn. J. Pharmacol. pmid:3936958
Lewis RA et al. Pharmacologic regulation of mediator generation and release from the murine bone marrow derived mast cell. 1985 Int. Arch. Allergy Appl. Immunol. pmid:2409010
Norman PS et al. Mediator release after allergic and physical nasal challenges. 1985 Int. Arch. Allergy Appl. Immunol. pmid:2409027
Schleimer RP et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. 1985 J. Allergy Clin. Immunol. pmid:2410478
Majewska MD and Chuang DM Benzodiazepines enhance the muscimol-dependent activation of phospholipase A2 in glioma C6 cells. 1985 J. Pharmacol. Exp. Ther. pmid:2857784
Lad PM et al. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. 1985 Biochim. Biophys. Acta pmid:2411298
Finney MJ et al. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. 1985 Br. J. Pharmacol. pmid:2411319
Fowler JC et al. Prostaglandins block a Ca2+-dependent slow spike afterhyperpolarization independent of effects on Ca2+ influx in visceral afferent neurons. 1985 Brain Res. pmid:2412652
Levi-Schaffer F et al. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. 1985 J. Immunol. pmid:2413121
Robin JL et al. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. 1985 J. Immunol. pmid:3161947
Beatty CH et al. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis. 1985 Atherosclerosis pmid:3924062
Westcott JY and Murphy RC Effect of alcohols on arachidonic acid metabolism in murine mastocytoma cells and human polymorphonuclear leukocytes. 1985 Biochim. Biophys. Acta pmid:2982416
Kasukabe T et al. Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1. 1985 Biochim. Biophys. Acta pmid:3855662
Narumiya S and Fukushima M delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. 1985 Biochem. Biophys. Res. Commun. pmid:3857041
Abbate R et al. Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemia. 1985 Atherosclerosis pmid:3857047
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Gause GE et al. Hemodynamic effects of postpulmonary administration of prostaglandin D2 in fetal animals. 1985 Proc. Soc. Exp. Biol. Med. pmid:3858885
Seregi A et al. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. 1985 Brain Res. pmid:3859353
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Nielsen JA and Sparber SB Central administration of prostaglandin E2 facilitates while F2 alpha attenuates acute dependence upon morphine rats. 1985 Pharmacol. Biochem. Behav. pmid:3860881
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Robinson C and Holgate ST Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. 1985 Clin. Sci. pmid:2981650
Pugliese G et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. 1985 J. Biol. Chem. pmid:3863819